INFLUENCE OF THE GENETIC POLYMORPHISMS ON THE RESPONSE TO CLOPIDOGREL IN PERIPHERAL ARTERY DISEASE PATIENTS FOLLOWING PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY